ATE433575T1 - Neurotransmission-störungen - Google Patents

Neurotransmission-störungen

Info

Publication number
ATE433575T1
ATE433575T1 AT01940736T AT01940736T ATE433575T1 AT E433575 T1 ATE433575 T1 AT E433575T1 AT 01940736 T AT01940736 T AT 01940736T AT 01940736 T AT01940736 T AT 01940736T AT E433575 T1 ATE433575 T1 AT E433575T1
Authority
AT
Austria
Prior art keywords
neurotransmission
bodily fluid
developmental disorders
mammal
musk
Prior art date
Application number
AT01940736T
Other languages
English (en)
Inventor
Angela Vincent
Werner Hoch
Original Assignee
Isis Innovation
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9893880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE433575(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Isis Innovation, Max Planck Gesellschaft filed Critical Isis Innovation
Application granted granted Critical
Publication of ATE433575T1 publication Critical patent/ATE433575T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01940736T 2000-06-16 2001-06-15 Neurotransmission-störungen ATE433575T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014878.3A GB0014878D0 (en) 2000-06-16 2000-06-16 Neurotransmission disorders
PCT/GB2001/002661 WO2001096601A2 (en) 2000-06-16 2001-06-15 Neurotransmission disorders

Publications (1)

Publication Number Publication Date
ATE433575T1 true ATE433575T1 (de) 2009-06-15

Family

ID=9893880

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01940736T ATE433575T1 (de) 2000-06-16 2001-06-15 Neurotransmission-störungen

Country Status (9)

Country Link
US (2) US7267820B2 (de)
EP (1) EP1327147B1 (de)
AT (1) ATE433575T1 (de)
AU (1) AU2001274239A1 (de)
CA (1) CA2455271C (de)
DE (1) DE60138958D1 (de)
ES (1) ES2327100T3 (de)
GB (1) GB0014878D0 (de)
WO (1) WO2001096601A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0014878D0 (en) * 2000-06-16 2000-08-09 Isis Innovation Neurotransmission disorders
EP2491389A4 (de) 2009-10-21 2013-07-31 Georgia Health Sciences University Res Inst Inc Erkennung und behandlung von mit lrp4 assoziierten neurotransmissionserkrankungen
GR1007341B (el) 2010-04-21 2011-07-05 ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ (κατά ποσοστό 40%), Διαγνωστικος προσδιορισμος
JP6240919B2 (ja) * 2014-04-03 2017-12-06 地方独立行政法人東京都健康長寿医療センター 加齢または筋萎縮の診断用バイオマーカー
US10093743B2 (en) * 2014-11-18 2018-10-09 Premkumar Christadoss Muscle specific tyrosine kinase-fluorophore conjugate compositions, kits and methods of using
EP3850015A1 (de) 2018-09-10 2021-07-21 Academisch Ziekenhuis Leiden h.o.d.n. LUMC Musk-aktivierung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814478A (en) * 1995-12-15 1998-09-29 Regeneron Pharmaceuticals, Inc. Tyrosine kinase receptors and ligands
US6342220B1 (en) 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
GB0014878D0 (en) * 2000-06-16 2000-08-09 Isis Innovation Neurotransmission disorders

Also Published As

Publication number Publication date
GB0014878D0 (en) 2000-08-09
US7267820B2 (en) 2007-09-11
EP1327147B1 (de) 2009-06-10
US7732147B2 (en) 2010-06-08
WO2001096601A2 (en) 2001-12-20
US20080057524A1 (en) 2008-03-06
DE60138958D1 (de) 2009-07-23
EP1327147A2 (de) 2003-07-16
US20040082010A1 (en) 2004-04-29
WO2001096601A3 (en) 2002-03-28
CA2455271A1 (en) 2001-12-20
AU2001274239A1 (en) 2001-12-24
ES2327100T3 (es) 2009-10-26
CA2455271C (en) 2012-10-16

Similar Documents

Publication Publication Date Title
BRPI0410261B8 (pt) anticorpo monoclonal que se liga especificamente ao probnp, métodos para detecção específica de probnp in vitro e para diagnóstico de insuficiência cardíaca in vitro, kit para medição de probnp, e linhagem celular de hibridoma mab 1.21.3
DE60335022D1 (de) Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel
DK0540573T4 (da) Assay for frit- og kompleksbundet prostataspecifikt antigen (PSA)
SE9502196D0 (sv) Ultrasensitive immunoassays
SI1232392T1 (en) Improved method for the detection of acid resistant bacteria of the genus helicobacter in stool
RU2005131842A (ru) Моноклональное антитело и продуцирующая его гибридома
ATE487946T1 (de) Analytischer sandwichtest zur bestimmung von nt- probnp
NO982265L (no) Diagnostikk for og mediatorer for inflammatoriske forstyrrelser
ATE326484T1 (de) Monoklonaler antikörper gegen flt4-rezeptor- tyrosinkinase und dessen verwendung zur diagnose und therapie
NO974534D0 (no) Bestemmelse av cPSA
ATE433575T1 (de) Neurotransmission-störungen
DK1214447T3 (da) Påvisning af pyruvatkinase-isoenzymer i fæces
EP1245957A3 (de) Methode zur Konzentrationsbestimmung von Ceruloplasmin in einem Blutflecken mittels enzymgekoppeltem Immunosorbent-Assay oder mittels dissoziationsverstärktem, zeitaufgelöstem Immunofluoreszenzassay, sowie Kit zum Auffinden der Wilson-Krankheit und Diagnosemethode für letztere
AU2002233800A1 (en) Method and kit for predicting cancer
DE69921987D1 (de) IMMUNTEST FÜR HUMAN CHROMOGRANINE A (CgA), ANTIKÖRPER, REAGENZ UND DAZU GEEIGNETER TESTSATZ
SE0202702D0 (sv) Immunoassays for specific determination of SCCA isoforms
SE0100595D0 (sv) Immunological detection of prostate diseases and prostatic-related diseases
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
DE50304756D1 (de) Verfaren zur diagnose von neoplasmen
EP0364971A3 (de) Verfahren zum Nachweis der Legionella-Antigene in Körperflüssigkeiten und dergleichen und eine Testzusammensetzung zur Durchführung des Verfahrens
FI20011517A0 (fi) Menetelmä alkoholinkulutuksen osoittamiseksi, menetelmässä käytettäviä välineitä sekä niiden valmistus
RU2001126943A (ru) Способ прогнозирования развития ретинопатии недоношенных
ATE290694T1 (de) Diagnose von autoimmun-nebennierenkrankheit
IT1317355B1 (it) Anticorpi policlonali.
ES2189254T3 (es) Dosificado inmunologico que permite detectar los anticuerpos igm especificos del citomegalovirus humano.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties